FORM 6-K
 

 

SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

 

Report of Foreign Issuer

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
 


For period ending January 2009
 

GlaxoSmithKline plc
(Name of registrant)
 
 

 

980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)
 
 

Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F
 
 

Form 20-F x Form 40-F
 

 --

Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
 
 
Yes No x
  --

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons


I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the 
Ordinary shares
 of GlaxoSmithKline plc
 
in respect of the under-mentioned 
person
s
 arising from the purchase of 
Ordinary shares
 at a price of £
12.82
 per Ordinary 
s
hare on 
8 January 2009
 
through the Company
'
s ShareReward Plan (
"
the Plan
"
) 
which 
the under-mentioned persons 
entered on 5 October 2001:

Mr A P Witty
Acquisition of 20
 Ordinary shares under the Dividend Reinvestment element of the Plan

Mr J S Heslop
Acqu
isition of 20
 Ordinary shares under the Dividend Reinvestment element of the Plan

Mr S M Bicknell
Acquisition of 20
 Ordinary shares under the Dividend Reinvestment element of the Plan

Mr E J Gray
Acquisition of 20
 Ordinary shares under the Dividend Reinvestment element of the Plan

Mr D Learmouth
Acquisition of 20
 Ordinary shares under the Dividend Reinvestment element of the Plan

Dr D Pulman
Acquisition of 8
 Ordinary shares under the Dividend Reinvestment element of the Plan

Mr D S Redfern
Acquisi
tion of 20
 Ordinary shares under the Dividend Reinvestment element of the Plan

Ms C Thomas
Acquisition of 20
 Ordinary shares under the Dividend Reinvestment element of the Plan




The Company and the above-mentioned persons were advise
d of this information on
 
9 January 2009
.

This notification relates to a transaction notified in accordance with
 
Disclosure
 and Transparency
 R
ule 3.1.4R(1)(a)
.


V A Whyte
Deputy Company Secretary
9 January 2009

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
 

GlaxoSmithKline plc
(Registrant)
 
 

Date: January 09 2009

By: VICTORIA WHYTE

------------------

Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc